Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 2
2004 4
2005 3
2006 2
2007 4
2008 5
2009 3
2010 3
2011 5
2012 8
2013 10
2014 4
2015 5
2016 6
2017 5
2018 6
2019 3
2020 8
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
KRAS signaling in malignant pleural mesothelioma.
Marazioti A, Krontira AC, Behrend SJ, Giotopoulou GA, Ntaliarda G, Blanquart C, Bayram H, Iliopoulou M, Vreka M, Trassl L, Pepe MAA, Hackl CM, Klotz LV, Weiss SAI, Koch I, Lindner M, Hatz RA, Behr J, Wagner DE, Papadaki H, Antimisiaris SG, Jean D, Deshayes S, Grégoire M, Kayalar Ö, Mortazavi D, Dilege Ş, Tanju S, Erus S, Yavuz Ö, Bulutay P, Fırat P, Psallidas I, Spella M, Giopanou I, Lilis I, Lamort AS, Stathopoulos GT. Marazioti A, et al. Among authors: gregoire m. EMBO Mol Med. 2022 Feb 7;14(2):e13631. doi: 10.15252/emmm.202013631. Epub 2021 Dec 13. EMBO Mol Med. 2022. PMID: 34898002 Free PMC article.
Impact of HDAC inhibitors on dendritic cell functions.
Frikeche J, Peric Z, Brissot E, Grégoire M, Gaugler B, Mohty M. Frikeche J, et al. Among authors: gregoire m. Exp Hematol. 2012 Oct;40(10):783-91. doi: 10.1016/j.exphem.2012.06.008. Epub 2012 Jun 19. Exp Hematol. 2012. PMID: 22728031 Free article. Review.
Oncolytic virotherapy for human malignant mesothelioma: recent advances.
Boisgerault N, Achard C, Delaunay T, Cellerin L, Tangy F, Grégoire M, Fonteneau JF. Boisgerault N, et al. Among authors: gregoire m. Oncolytic Virother. 2015 Sep 10;4:133-40. doi: 10.2147/OV.S66091. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512676 Free PMC article. Review.
[New diagnostic markers for malignant pleural mesothelioma].
Grigoriu BD, Grégoire M, Chahine B, Scherpereel A. Grigoriu BD, et al. Among authors: gregoire m. Bull Cancer. 2008 Feb;95(2):177-84. doi: 10.1684/bdc.2008.0576. Bull Cancer. 2008. PMID: 18304902 Free article. Review. French.
Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma.
Jean D, Delaunay T, Meiller C, Boisgerault N, Grard M, Caruso S, Blanquart C, Felley-Bosco E, Bennouna J, Tangy F, Grégoire M, Fonteneau JF. Jean D, et al. Among authors: gregoire m. J Thorac Oncol. 2020 Jul;15(7):e113-e116. doi: 10.1016/j.jtho.2020.04.011. J Thorac Oncol. 2020. PMID: 32593448 Free article. No abstract available.
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T, d'Almeida SM, Briolay T, Tabiasco J, Meiller C, Chéné AL, Cellerin L, Deshayes S, Delneste Y, Fonteneau JF, Boisgerault N, Bennouna J, Grégoire M, Jean D, Blanquart C. Blondy T, et al. Among authors: gregoire m. J Immunother Cancer. 2020 Jun;8(1):e000182. doi: 10.1136/jitc-2019-000182. J Immunother Cancer. 2020. PMID: 32581053 Free PMC article.
83 results